Buscar

01/04/2026 Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)
Monge, A, Martinez-De las Fuentes, AM, Burgos, J, Pou, C, Lakhani, JS, Navarro, A, Castanon, RA, Garcia-Urrestarazu, EJ, Sayés, A, Alcaide, AB, Erro, M, Moreno, BR, Sánchez-Cucó, A, Santisteve, S, Benitez, ID, Moncusi-Moix, A, Gracia-Lavedan, E, Manzano, C, Morales, A, Barbé, F, Suarez-Cuartin, G, de la Rosa-Carrillo, D, de-Torres, JP, González, J. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(4)DOI:10.1016/j.arbres.2025.10.017. PMID:41253672. IF:9.200(Q1/1D).
01/02/2026 LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY
Lázaro, AR, Mediano, O, Cano, I, Egea, C, Monasterio, M, Muñoz, C, Podzamczer, I, Gonzalez, M, Grau, N, Cabriada, V, Cano, MDP, Dalmases, M, Salord, N, Castelló, C, Ramos, A, Lores, V, Arias, B, Jara, B, Ruiz, C, Horrillo, A, Romero, S, Pozuelo, L, Martinez, D, Boukichou, N, Barbé, F, de la Torre, MS. LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).
01/01/2026 Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study
Gessner, C, Russell, REK, Greulich, T, Lommatzsch, M, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Kupczyk, M, Braido, F, Piraino, A, Scaffidi-Argentina, U, Bogoevska, V, Trinkmann, F. Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study. Journal of Asthma and Allergy. 2026; 19DOI:10.2147/JAA.S582286. PMID:41767174. IF:3.000(Q2/4D).
01/03/2026 REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE
Harniman, K, Gessner, C, Bogoevska, V, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE. INTERNAL MEDICINE JOURNAL. 2026; 56DOI:. PMID:. IF:1.500(Q2/5D).
13/04/2026 Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis
Blanco, R, Rua-Figueroa, I, Blanco-Aparicio, M, Casafont-Solé, I, Espígol-Frigolé, G, García-Moguel, I, Plaza, V, Soto-Campos, G. Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1785849. PMID:42051495. IF:5.900(Q1/2D).
01/07/2025 FEV1Q as a Predictive Metric for Asthma Outcomes
Betancor, D, Olaguibel, JM, del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cardaba, B, Cañas, JA, Domínguez-Ortega, J, Cruz, MJ, Curto, E, Garcia de la Fuente, A, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto-Retes, L, Valverde-Monge, M, Mahíllo-Fernández, I, Sastre, J. FEV1Q as a Predictive Metric for Asthma Outcomes. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(7)DOI:10.1016/j.arbres.2025.02.011. PMID:40087119. IF:9.200(Q1/1D).
01/03/2026 SEPAR Recommendations on Vaccination for Chronic Respiratory Patients
de Miguel-Díez, J, Torres-Castro, R, Herrero, FS, Villanueva, RM, Gómez, BS, Fernández, SQ, Rojo, RP, Cuesta, VMM, Castillo, ME, Fernández, LS, Martínez, MMC, Mediano, O, García-Ortega, A, Rivero, JLG, de la Rosa-Carrillo, D. SEPAR Recommendations on Vaccination for Chronic Respiratory Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(3)DOI:10.1016/j.arbres.2025.06.005. PMID:40592680. IF:9.200(Q1/1D).
01/07/2025 Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).
Almonacid C, Blanco M, Ferreira J, García G, Morete A, Quirce S, Soto-Campos G, Plaza V. Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100453. PMID:40677934. IF:(Q/D).
01/11/2025 Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy
Serra-Lopez, J, Miranda, A, Soria, A, Lopez, N, Castañon, E, Majem, M. Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy. Enfermeria Clinica. 2025; 35(6)DOI:10.1016/j.enfcle.2025.502193. PMID:40204238. IF:(Q/D).
01/08/2023 Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles
Martinez-Torro, C, Alba-Castellon, L, Carrasco-Diaz, LI, Serna, N, Imedio, L, Gallardo, A, Casanova, I, Unzueta, U, Vazquez, E, Mangues, R, Villaverde, A. Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 164DOI:10.1016/j.biopha.2023.114976. PMID:37276641. IF:6.900(Q1/1D).
29/04/2026 Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD
Fonseca-Santos, M, Puertas, B, Arzuaga-Méndez, J, Ancin-Arteaga, I, Castaño-Diez, S, De Miguel, C, Canet-Maldonado, M, Bosch-Schips, M, Palomo-Rumschisky, P, Blanco, ML, Gil-Alós, D, Moreno-Igoa, M, Santa-Catalina, PG, Azibeiro, R, Puerta, C, Mesa-Tudela, A, López-Cadenas, F, Tuset, E, Fiallo-Suarez, DV, Ramos, F, Gimenez, MT, Peri, V, Mayani, K, Montañes-García, MA, Villalba, A, Rivas, JMH, Díaz-Beyá, M, Díez-Campelo, M. Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1743509. PMID:42136657. IF:5.900(Q1/2D).
01/03/2026 Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils
Merino, A, Barrera, K, Verdú, G, San José, P, Vallbé, M, Molina, A, Rodellar, J. Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils. International Journal of Laboratory Hematology. 2026; 48DOI:. PMID:. IF:2.300(Q2/5D).
01/06/2023 Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.. BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01967-9. PMID:37076611. IF:(Q/D).
01/04/2026 Influence of the level of education on cognitive function in Parkinson's disease
Santos-García, D, Fonticoba, TD, Bartolomé, CC, Alvarado, MCI, Samaniego, L, Maside, AL, Gallego, L, Barreiro, LC, Caramés, JR, Painceiras, MJF, González, JMP, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Influence of the level of education on cognitive function in Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2026; 133(4)DOI:10.1007/s00702-025-03074-z. PMID:41428073. IF:4.000(Q1/2D).
17/10/2025 Perceptions of neuromuscular electrostimulation of patients with Parkinson's disease and their caregivers: the impact on swallowing and speech from a qualitative perspective
Simao, MD, Poveda-Moral, S, Daniel, ER, Ganora, AD, Vargas, MV, Kulisevsky, J. Perceptions of neuromuscular electrostimulation of patients with Parkinson's disease and their caregivers: the impact on swallowing and speech from a qualitative perspective. Journal Of Patient-Reported Outcomes. 2025; 9(1)DOI:10.1186/s41687-025-00931-z. PMID:41105286. IF:(Q/D).
19/02/2026 Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study
Luquin, M, Lopez-Ariztegui, N, Castrillo, JCM, Manzanares, LL, Bataller, IS, Fernández, AK, Pastor, BV, Vila, BS, Sauco, MA, Mora, JP, González, JMA, Ruiz-Espiga, PJG, de Fàbregues, O, del Val, JL, Arillo, VC, Moreno, C, Ameijeiras, JB, Jiménez, IP, Ayuela, IT. Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study. Frontiers in Neurology. 2026; 17DOI:10.3389/fneur.2026.1738500. PMID:41798821. IF:2.800(Q2/5D).
02/01/2026 Validation of the Spanish version of the cerebellar cognitive-affective syndrome scale
Serrano-Munuera, C, Martínez-Regueiro, R, Fernández, EMM, Perna, BA, Domínguez, DL, Rojas-Bartolomé, L, Gómez, AA, Torre, PP, Abildúa, MJA, Axpe, IR, Feria-Vilar, I, Pérez, JP, Schmahmann, JD, García-Sánchez, C. Validation of the Spanish version of the cerebellar cognitive-affective syndrome scale. CLINICAL NEUROPSYCHOLOGIST. 2026; 40(1)DOI:10.1080/13854046.2025.2488453. PMID:40260849. IF:2.700(Q2/3D).
01/12/2025 A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms
Stocchi, F, Kulisevsky, J, Jost, WH. A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms. Movement Disorders Clinical Practice. 2025; 12(12)DOI:10.1002/mdc3.70188. PMID:40545913. IF:2.700(Q2/5D).
01/01/2025 Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations.
Perez-Rando M., Penades-Gomiz C., Martinez-Marin P., García-Martí G., Aguilar E.J., Escarti M.J., Grasa E., Corripio I., Sanjuan J., Nacher J.. Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations.. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(4)DOI:10.1016/j.rpsm.2023.05.002. PMID:37495479. IF:(Q/D).
04/07/2024 Spanish experts consensus on emergency psychiatric care in hospital emergency departments
Gordillo-Urbano, RM, Crespo-Facorro, B, Pérez-Solá, V, Cardoner, N, García-Ligero, E, Moreno, C, Ramos-Quiroga, JA, Ruiz-Veguilla, M, Vázquez-Vallejo, M, Prados-Ojeda, JL. Spanish experts consensus on emergency psychiatric care in hospital emergency departments. BMC Psychiatry. 2024; 24(1)DOI:10.1186/s12888-024-05939-1. PMID:38965477. IF:3.600(Q1/3D).